<p>Is there a faster way to identifying the root cause of a patient's excessive bleeding? Philip Young, President & CEO of Exactus, Inc. (OTCQB: EXDI) explains how the company's Point-of-Care (POC) diagnostics for measuring proteolytic enzymes in the blood are designed to help physicians.</p>

Is there a faster way to identifying the root cause of a patient's excessive bleeding? Philip Young, President & CEO of Exactus, Inc. (OTCQB: EXDI) explains how the company's Point-of-Care (POC) diagnostics for measuring proteolytic enzymes in the blood are designed to help physicians.

<p>Is there a faster way to identifying the root cause of a patient's excessive bleeding? Philip Young, President &amp; CEO of Exactus, Inc. (OTCQB: EXDI) explains how the company's Point-of-Care (POC) diagnostics for measuring proteolytic enzymes in the blood are designed to help physicians.</p>

Exactus, Inc.

OTC Markets presents our podcast series on the OTCQB Market, where we interview the entrepreneurs behind the companies that trade on the venture market.

Share Exactus, Inc.

Sign up to save your podcasts

Exactus, Inc.

Exactus, Inc.